Treatment with Anti-VEGF and anti-EGFR in a model of malignant pleural effusion: Genic evaluation

L. Ribeiro Teixeira (Sao Paulo, Brazil), V. Alvarenga (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), N. Almeida (Sao Paulo, Brazil), L. Sousa (Sao Paulo, Brazil), A. Santos (Sao Paulo, Brazil), V. Capelozzi (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil)

Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management

Session: Mesothelioma and pleural malignancy: investigations and management
Session type: Thematic Poster
Number: 2862

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Ribeiro Teixeira (Sao Paulo, Brazil), V. Alvarenga (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), N. Almeida (Sao Paulo, Brazil), L. Sousa (Sao Paulo, Brazil), A. Santos (Sao Paulo, Brazil), V. Capelozzi (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil). Treatment with Anti-VEGF and anti-EGFR in a model of malignant pleural effusion: Genic evaluation. 2862

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Malignant pleural effusion: treatment of the fluid and intrapleural therapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
Pleurodesis for malignant pleural effusion: which compound? Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Pleurodesis for malignant pleural effusion: which compound? Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Systemic therapy 2 in malignant pleural mesothelioma: immuno- & targeted therapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Management of malignant pleural effusions Source: Eur Respir J 2001; 18: 402-419 Year: 2001
Management of malignant pleural effusions Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
Management of malignant pleural effusions Source: Guideline 2001 Year: 2001
Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004
Malignant pleural mesothelioma: our multimodality approach Source: Eur Respir J 2002; 20: Suppl. 38, 40s Year: 2002
Management of recurrent malignant pleural effusions Source: ERS Skills Course 2016 - Thoracoscopy and pleural techniques Year: 2016